Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-18

FDA Approved: TRIKAFTA — Supplemental Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

FDA supplemental approval action for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor) submitted by Vertex Pharmaceuticals; this action updates the regulatory status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

SUPPL AP for TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)